skip to Main Content

Beyond “Poz” and “Neg”: Five HIV Statuses, Plus a New One

To have a meaningful conversation about HIV status, people should corner intentions and sexual partners in the realm of actuality, by keeping it to-the-point and asking the following questions: “When did you last test for HIV? What was the test result?” Equally important is to open minds to reality by remembering that the time of binary HIV statuses is pretty much over.
I can count five HIV statuses, plus a new one. They entail different responsibilities, possibilities and risks.

Read More

New Antiretroviral Injection Shows 100% Protection Rate From HIV

Researchers at Columbia University’s Mailman School of Public Health have found that an injection of antiretroviral drugs can give 100 percent protection from HIV.
Monkeys were injected with the drugs in two separate trials, with protection lasting a month. However, research suggests that such an injection could last for up to three months, reports the New York Times.

Read More

Truvada as PrEP Does Not Cause Kidney Damage, Study Suggests

Taking tenofovir/emtricitabine (Truvada) as pre-exposure prophylaxis (PrEP) has little effect on kidney function, according to a study recently published in AIDS. The study, known as IPrEx (Iniciativa Profilaxis Pre-Exposicion), showed a very mild decrease in creatinine clearance (CrCl)—a measure of kidney function—among participants taking Truvada, but the change was reversible, as CrCl returned to baseline levels after the drug was discontinued at the end of the study.

Read More
Back To Top
×Close search
Search